Press Releases

Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting

November 3, 2016

Poseida Therapeutics Establishes Scientific Advisory Board

September 8, 2016

Poseida Therapeutics Expands Executive Leadership Team

August 18, 2016

Poseida Therapeutics Announces Series A Financing

December 16, 2015

Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies

August 11, 2015

Poseida Therapeutics, Inc., Expands Board of Directors

August 5, 2015

Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference

June 1, 2015

Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies

June 1, 2015